Psychological Techniques to Promote Adherence
Adherence is a multifaceted behavioral process involving individuals, families, medical providers, communities, and health-care systems. Each of these factors represents a target for behavioral interventions to improve patient adherence. This chapter will describe adherence interventions centred on psychological principles of patients, health care providers, and health systems. Patient-based psychological approaches involve developing self-management techniques, or learning how particular behaviors associate with a health outcome, such as cognitive behavioral therapy. Physician-based strategies involve using motivational interviewing to help patients better understand their behavior and its consequences, or developing a sense of accountability in the patient-provider relationship. System-based approaches include scheduling longer appointment times, continuity of care, and communication with patients. Psychology offers useful theories, models, and strategies to promote practical strategies to promote adherence in patients suffering from chronic dermatological conditions.
KeywordsAdherence Compliance Dermatology Educational interventions Intentional nonadherence Unintentional nonadherence
Conflicts of Interest
Dr. Steven R. Feldman is a speaker for Taro. He is a consultant and speaker for Galderma, Abbvie, Celgene, Abbott Labs, Lilly, Janssen, Novartis Pharmaceuticals and Leo Pharma Inc. Dr. Feldman has received grants from Galderma, Janssen, Abbott Labs, Abbvie, Celgene, Taro, Sanofi, Celgene, Novartis Pharmaceuticals, Qurient, Pfizer Inc. and Anacor. He is a consultant for Advance Medical, Caremark, Gerson Lehrman Group, Guidepoint Global, Kikaku, Lilly, Merck & Co Inc., Mylan, Pfizer Inc., Qurient, Sanofi, Sienna, Sun Pharma, Suncare Research, Valeant, and Xenoport. Dr. Feldman is the founder, chief technology officer and holds stock in Causa Research. Dr. Feldman holds stock and is majority owner in Medical Quality Enhancement Corporation. He receives Royalties from UpToDate, Informa and Xlibris.
Dr. Adrian Pona, Dr. Abigail Cline, Dr. Masicampo, Monica Shah, and Felicia Tai have no conflicts of interest to disclose.
- 9.Neri L, Peris K, Longo C, Calvieri S, Frascione P, Parodi A, et al. Physician-patient communication and patient-reported outcomes in the actinic keratosis treatment adherence initiative (AK-TRAIN): a multicenter, prospective, real-life study of treatment satisfaction, quality of life and adherence to topical field-directed therapy for the treatment of actinic keratosis in Italy. J Eur Acad Dermatol Venereol. 2019;33(1):93–107.CrossRefPubMedGoogle Scholar
- 11.Craşovan DI, Sava FA. Translation, adaptation, and validation on Romanian population of COPE questionnaire for coping mechanisms analysis. Cogn Brain Behav. 2013;17(1):61–76.Google Scholar
- 18.Beck JS. Cognitive behavior therapy: basics and beyond: New York: Guilford Press; 2011.Google Scholar
- 31.Santer M, Muller I, Yardley L, Burgess H, Selinger H, Stuart BL, et al. Supporting self-care for families of children with eczema with a web-based intervention plus health care professional support: pilot randomized controlled trial. J Med Internet Res. 2014;16(3):e70.CrossRefPubMedPubMedCentralGoogle Scholar
- 33.Ersser SJ, Cowdell F, Latter S, Gardiner E, Flohr C, Thompson AR, et al. Psychological and educational interventions for atopic eczema in children. Cochrane Database Syst Rev. 2014;1:CD004054.Google Scholar
- 36.Ersser SJ, Cowdell FC, Nicholls PG, Latter SM, Healy E. A pilot randomized controlled trial to examine the feasibility and efficacy of an educational nursing intervention to improve self-management practices in patients with mild-moderate psoriasis. J Eur Acad Dermatol Venereol. 2011;26(6):738–45.CrossRefPubMedGoogle Scholar
- 38.Thorneloe RJ, Bundy C, Griffiths CEM, Ashcroft DM, Cordingley L. Nonadherence to psoriasis medication as an outcome of limited coping resources and conflicting goals: findings from a qualitative interview study with people with psoriasis. Br J Dermatol. 2017;176(3):667–76.CrossRefPubMedGoogle Scholar
- 39.National Collaborating Centre for Primary C. National Institute for Health and Clinical Excellence: Guidance. Medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence. London: Royal College of General Practitioners (UK); 2009.Google Scholar
- 45.Rubin DT, Mittal M, Davis M, Johnson S, Chao J, Skup M. Impact of a patient support program on patient adherence to adalimumab and direct medical costs in Crohn’s disease, ulcerative colitis, rheumatoid arthritis, psoriasis, psoriatic arthritis, and ankylosing spondylitis. J Manag Care Spec Pharm. 2017;23(8):859–67.PubMedGoogle Scholar
- 46.Miller WR, Rollnick S. Motivational interviewing: helping people change: New York: Guilford Press; 2012.Google Scholar
- 56.Carroll CL, Feldman SR, Camacho FT, Manuel JC, Balkrishnan R. Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual use. J Am Acad Dermatol. 2004;51(2):212–6.CrossRefPubMedGoogle Scholar
- 61.Sabate E, Sabaté E, Organisation mondiale de la s, World Health O, Unaids. Adherence to long-term therapies: evidence for action. New York: World Health Organization; 2003.Google Scholar
- 64.Fenerty SD, West C, Davis SA, Kaplan SG, Feldman SR. The effect of reminder systems on patients’ adherence to treatment. Patient Prefer Adherence. 2012;6:127–35.Google Scholar
- 65.Yelamos O, Ros S, Puig L. Improving patient outcomes in psoriasis: strategies to ensure treatment adherence. Psoriasis (Auckland, NZ). 2015;5:109–15.Google Scholar